Evaluating clinical and pathologic predictors for pathologic lymph node positivity (pN+) in patients with clinical T1-4N0M0 bladder cancer undergoing cystectomy.
Jaime-Casas S, Barragan-Carrillo R, Zugman M, Zang P, Ebrahimi H, Castro D, Mercier B, Li X, Dizman N, Salgia N, Hsu J, Nguyen C, Yip W, Chehrazi-Raffle A, Zengin Z, Meza L, Pal S, Tripathi A. Evaluating clinical and pathologic predictors for pathologic lymph node positivity (pN+) in patients with clinical T1-4N0M0 bladder cancer undergoing cystectomy. Journal Of Clinical Oncology 2025, 43: 877-877. DOI: 10.1200/jco.2025.43.5_suppl.877.Peer-Reviewed Original ResearchConcomitant carcinoma in situRecurrence-free survivalPositive surgical marginsLymph node positivityRadical cystectomyLymphovascular invasionOverall survivalPreoperative hydronephrosisSurgical marginsPathologic predictorsBladder cancerPredictors of lymph node positivityConcomitant CISMultivariate analysisPathologic lymph node positivityPelvic lymph node dissectionPathological lymph node involvementMultivariate Cox proportional hazards modelMultivariate Cox regression modelNode-positiveBladder-preserving approachPreoperative renal functionLymph node dissectionLymph node involvementCarcinoma in situ
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply